Face Cream
Natural health product licensed in Canada
- Other names
- Active ReLeaf Face Cream
- Licence holder
- Active ReLeaf Wellness Inc.
- NPN or DIN-HM
- 80122570
- Status
- Inactive licence
- Licence date
- 4 January 2023
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Arnica montana Source : Fleur | 2.45 % |
Non-medicinal ingredients
Triéthanolamine, Sorbate de potassium, Beurre de karité, Glycérine, Vitamine E, Phénoxyéthanol, Esters d'aminopropanediol d'huile d'argan, Acide citrique, Huile de Prunus amygdalus dulcis (Amande douce), Cire mise en émulsion, Eau distillée, Extrait de feuilles d'Aloe barbadensis
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Traditionally) used in Herbal Medicine to help relieve pain and/or inflammation in muscles and joints (e.g. sprains, bruises, joint pain).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80122570
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.